Biomarkers in Ovarian Cancer: Roundtable Policy Brief
In December 2025, the World Ovarian Cancer Coalition convened patients, clinicians, researchers, and policy leaders to examine global access to biomarker testing in ovarian cancer.
Biomarker-informed care, including BRCA and HRD testing, is transforming treatment. Yet major inequities persist.